Kayne Anderson Rudnick Investment Management LLC Tandem Diabetes Care Inc Transaction History

Kayne Anderson Rudnick Investment Management LLC

$39.3 Billion
Q1 2025

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$53.22 - $123.09 $372 - $861	-7 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $713 - $1,050	7 New	7 $1,000
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $243 - $313	-3 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $259 - $365	3 New	3 $0

Others Institutions Holding TNDM

# of Institutions

298

Shares Held

72.2M

Call Options Held

3.12M

Put Options Held

159K

Black Rock Inc. New York, NY

11.1M
Shares

$175 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.29M
Shares

$115 Million
0.0% of portfolio
Sessa Capital Im, L.P. New York, NY

4.47M
Shares

$70.3 Million
3.55% of portfolio
Gw&K Investment Management, LLC Boston, MA

2.86M
Shares

$45.1 Million
0.51% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

2.72M
Shares

$42.8 Million
0.95% of portfolio

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.01B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account